LONG BEACH, Calif., and BASEL, Switzerland, May 24, 2022 — Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that the U.S. Food and Drug…Original Article
FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults
